FREDUNPharmaceuticals
Fredun Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹1671.80
-1.27%
Current P/E46.38xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E28.7x61.9% above avg
⚠️
46.0% Premium to Industry
FREDUN P/E 46.38x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹44.83 | ₹1578 | 35.2x |
| 2024 | ₹33.32 | ₹737 | 22.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Fredun Pharmaceuticals Ltd Valuation
Fredun Pharmaceuticals Ltd (FREDUN) currently trades at 46.38x earnings. The Pharmaceuticals sector average PE is 31.77x. FREDUN commands a premium, reflecting high growth expectations. Historically, FREDUN has traded at an average PE of 28.7x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
N/A
Dividend Yield
0.04%
More on Fredun Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.